Brimonidine recalls
The FDA has published 9 recalls involving Brimonidine since 2017. The latest was reported on 25 Mar 2026. Most were for potency & assay. Apotex has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls9since 2017
Last 12 months1reported
Class I00% of total
Ongoing3latest 25 Mar 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 5 56%Class III 4 44%
Why brimonidine is recalled
Companies
Brands
By year
Ongoing brimonidine recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recalledBrimonidine Tartrate/timolol Maleate Ophthalmic Solution | Apotex | Sterility | Nationwide |
| Drug | CLASS II | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution recalledBrimonidine Tartrate/timolol Maleate Ophthalmic Solution | Apotex | Sterility | Nationwide |
| Drug | CLASS II | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5% recalledBrimonidine Tartrate/timolol Maleate Ophthalmic Solution | Apotex | Sterility | Nationwide |
All brimonidine recalls, newest first
9 totalShould you stop taking Brimonidine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.